SEC Form 4 · accession 0001424422-18-000007
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Morlock
Director
Period of report
Oct 18, 2018
Accepted (ET)
Oct 22, 2018 · 6:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Oct 18, 2018 | S | 439,099 | $0.19 | D | 434,857 | D | |
| Common stock | Oct 19, 2018 | S | 214,091 | $0.18 | D | 220,766 | D | |
| Common stock | Oct 22, 2018 | S | 220,766 | $0.18 | D | 0 | D | |
| Common stock | Oct 22, 2018 | S | 251,071 | $0.18 | D | 0 | I | By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 |
Table II — derivative securities
No Table II lines on this filing.